Star Equity Non Currrent Assets Other Over Time
| STRR Stock | USD 3.04 0.24 8.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Star Equity Performance and Star Equity Correlation. Star |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Star Equity. If investors know Star will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Star Equity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.22) | Earnings Share (1.96) | Revenue Per Share 14.765 | Quarterly Revenue Growth 0.516 | Return On Assets (0.07) |
The market value of Star Equity Holdings is measured differently than its book value, which is the value of Star that is recorded on the company's balance sheet. Investors also form their own opinion of Star Equity's value that differs from its market value or its book value, called intrinsic value, which is Star Equity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Star Equity's market value can be influenced by many factors that don't directly affect Star Equity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Star Equity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Star Equity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Star Equity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Currrent Assets Other Analysis
Compare Star Equity Holdings and related stocks such as Genetic Technologies, Intelligent Bio Solutions, and bioAffinity Technologies, Non Currrent Assets Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GENE | 3.1 M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (2.5 M) | (69.3 K) | (440.2 K) | (9.5 M) | (6.1 M) | (4.2 M) | 81.7 K | 85.8 K |
| INBS | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 866.7 K | 866.7 K | 1.1 M | 1.1 M | 983.5 K | 1 M |
| BIAF | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 12.5 K | 17.5 K | 10.4 K | 6 K | 16.1 K | 10 K |
| TMO | 15.9 M | 551.7 M | (2 B) | (1.6 B) | (303.3 M) | (2.6 B) | (2.6 B) | (2.8 B) | 1.1 B | 1.9 B | 2.5 B | 4.4 B | (2.8 B) | 2.1 B | 2.2 B |
| ILMN | 34.6 K | 59.7 M | 73.2 M | 56.1 M | 64.7 M | 87.5 M | 107.2 M | 312 M | 308 M | 105 M | 171 M | 445 M | 423 M | 217 M | 123.4 M |
| DHR | 20.7 M | 739.7 M | 858 M | 676.1 M | 766.5 M | 817.9 M | 461.2 M | 492.9 M | 648.4 M | 1.7 B | 2.4 B | 3.7 B | 4.5 B | 3.6 B | 3.8 B |
| WAT | 29.7 M | 55 M | 100.2 M | 101.3 M | 125.3 M | 221.9 M | 200.8 M | 204.2 M | 186.7 M | 298 M | 322.2 M | 328.7 M | 381.5 M | 210.9 M | 140 M |
| IDXX | 700 K | 289.8 M | 13 M | 10.9 M | 23.2 M | 33.5 M | 53 M | 101 M | 170.2 M | 299 M | 337.2 M | 397.4 M | 425.6 M | 333 M | 349.6 M |
| ISPC | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 154.6 K | 207.1 K | 27.6 K | 27.6 K | 27.6 K | 24.8 K | 23.6 K |
Star Equity Holdings and related stocks such as Genetic Technologies, Intelligent Bio Solutions, and bioAffinity Technologies, Non Currrent Assets Other description
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.My Equities
My Current Equities and Potential Positions
| Star Equity Holdings | STRR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Georgia; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.04
Additional Tools for Star Stock Analysis
When running Star Equity's price analysis, check to measure Star Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Equity is operating at the current time. Most of Star Equity's value examination focuses on studying past and present price action to predict the probability of Star Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Equity's price. Additionally, you may evaluate how the addition of Star Equity to your portfolios can decrease your overall portfolio volatility.